Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript

This publication has 29 references indexed in Scilit:

• Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
  Nature Medicine, 2006
• Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide
  The Journal of Gene Medicine, 2005
• 128th ENMC International Workshop on ‘Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy’ 22–24 October 2004, Naarden, The Netherlands
  Neuromuscular Disorders, 2005
• Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense
  American Journal of Human Genetics, 2004
• Dystrophin and mutations: one gene, several proteins, multiple phenotypes
  The Lancet Neurology, 2003
• Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
  Neuromuscular Disorders, 2002
• Becker muscular dystrophy with onset after 60 years
  Neurology, 1994
• Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
  Nature, 1990
• Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy gene
  Trends in Biochemical Sciences, 1989
• An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus
  Genomics, 1988